MOLECULAR SWITCH FOR SIGNAL TRANSDUCTION - STRUCTURAL DIFFERENCES BETWEEN ACTIVE AND INACTIVE FORMS OF PROTOONCOGENIC RAS PROTEINS

被引:952
作者
MILBURN, MV
TONG, L
DEVOS, AM
BRUNGER, A
YAMAIZUMI, Z
NISHIMURA, S
KIM, SH
机构
[1] UNIV CALIF BERKELEY,DEPT CHEM,BERKELEY,CA 94720
[2] UNIV CALIF BERKELEY LAWRENCE BERKELEY LAB,BERKELEY,CA 94720
[3] YALE UNIV,HOWARD HUGHES MED INST,NEW HAVEN,CT 06511
[4] YALE UNIV,DEPT MOLEC BIOPHYS & BIOCHEM,NEW HAVEN,CT 06511
[5] NATL CANC CTR,RES INST,DIV BIOL,TOKYO 104,JAPAN
关键词
D O I
10.1126/science.2406906
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Ras proteins participate as a molecular switch in the early steps of the signal transduction pathway that is associated with cell growth and differentiation. When the protein is in its GTP complexed form it is active in signal transduction, whereas it is inactive in its GDP complexed form. A comparison of eight three-dimensional structures of ras proteins in four different crystal lattices, five with a nonhydrolyzable GTP analog and three with GDP, reveals that the "on" and "off" states of the switch are distinguished by conformational differences that span a length of more than 40 Å, and are induced by the γ-phosphate. The most significant differences are localized in two regions: residues 30 to 38 (the switch I region) in the second loop and residues 60 to 76 (the switch II region) consisting of the fourth loop and the short α-helix that follows the loop. Both regions are highly exposed and form a continuous strip on the molecular surface most likely to be the recognition sites for the effector and receptor molecule(or molecules). The conformational differences also provide a structural basis for understanding the biological and biochemical changes of the proteins due to oncogenic mutations, autophosphorylation, and GTP hydrolysis, and for understanding the interactions with other proteins.
引用
收藏
页码:939 / 945
页数:7
相关论文
共 34 条
[1]   GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN (GAP) INTERACTS WITH THE P21-RAS EFFECTOR BINDING DOMAIN [J].
ADARI, H ;
LOWY, DR ;
WILLUMSEN, BM ;
DER, CJ ;
MCCORMICK, F .
SCIENCE, 1988, 240 (4851) :518-520
[2]   RAS GENES [J].
BARBACID, M .
ANNUAL REVIEW OF BIOCHEMISTRY, 1987, 56 :779-827
[3]  
BRUNGER A, IN PRESS ACTA CRYST
[4]  
BRUNGER AT, UNPUB
[5]  
BRUNGER AT, 1988, X PLOR MANUAL VERSIO
[6]   THE CYTOPLASMIC PROTEIN GAP IS IMPLICATED AS THE TARGET FOR REGULATION BY THE RAS GENE-PRODUCT [J].
CALES, C ;
HANCOCK, JF ;
MARSHALL, CJ ;
HALL, A .
NATURE, 1988, 332 (6164) :548-551
[7]  
CASY PJ, 1989, P NATL ACAD SCI USA, V86, P8323
[8]   3-DIMENSIONAL STRUCTURE OF AN ONCOGENE PROTEIN - CATALYTIC DOMAIN OF HUMAN C-H-RAS P21 [J].
DEVOS, AM ;
TONG, L ;
MILBURN, MV ;
MATIAS, PM ;
JANCARIK, J ;
NOGUCHI, S ;
NISHIMURA, S ;
MIURA, K ;
OHTSUKA, E ;
KIM, SH .
SCIENCE, 1988, 239 (4842) :888-893
[9]  
FEUERSTEIN J, 1989, J BIOL CHEM, V264, P6188
[10]   MERLOT, AN INTEGRATED PACKAGE OF COMPUTER-PROGRAMS FOR THE DETERMINATION OF CRYSTAL-STRUCTURES BY MOLECULAR REPLACEMENT [J].
FITZGERALD, PMD .
JOURNAL OF APPLIED CRYSTALLOGRAPHY, 1988, 21 (03) :273-278